VRXA · Veraxa Biotech AG - Post de-SPAC

NasdaqHealthcareBiotechnology

Veraxa Biotech Holding Ag Focus On Antibody Therapies In Medicine. The Company Is An Oncology-Focused Biotechnology Company With A Clinical Program In Acute Myeloid Leukemia And Two Proprietary Platform Technologies That Enable The Development Of New Generations Of Antibody Drug Conjugates (Adc'S) And T Cell Engagers. The Company Operates In One Reportable Segment, Focused On The Research And Development Of Products For The Aging Population.

HealthcareNasdaqDE

FLOAT

51.9M

FREE FLOAT %

37%

SHARES O/S

141.4M

MARKET CAP

$141.4M

EXCHANGE

Nasdaq

COUNTRY

VRXA Catalyst History

No catalysts recorded for VRXA yet

Day Trader Sniper hasn't classified a publishable catalyst for VRXA yet. New events appear here as they're scored.

Be early on the next VRXA spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

VRXA · Veraxa Biotech AG - Post de-SPAC

VRXA Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.